U.S. Court of Appeals for the Federal Circuit
Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Company
This writing
- Type
- Opinion
- Filed
- Feb. 7, 2019
- Case
- Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Company
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Newman, Circuit Judge. Momenta Pharmaceuticals, Inc. ("Momenta") appeals the decision of the Patent Trial and Appeal Board ("PTAB" or "Board") sustaining patentability of claims 1 through 15 (all the claims) of United States Patent No. 8,476,239 ("the '239 Patent") owned by Bristol-Myers Squibb Company ("BMS"). 1 The appeal i…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.